DE60040348D1 - R verwendung des diphtheria-toxins - Google Patents

R verwendung des diphtheria-toxins

Info

Publication number
DE60040348D1
DE60040348D1 DE60040348T DE60040348T DE60040348D1 DE 60040348 D1 DE60040348 D1 DE 60040348D1 DE 60040348 T DE60040348 T DE 60040348T DE 60040348 T DE60040348 T DE 60040348T DE 60040348 D1 DE60040348 D1 DE 60040348D1
Authority
DE
Germany
Prior art keywords
diphtheria toxin
screening
modulators
secretion
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60040348T
Other languages
English (en)
Inventor
Todd M Kinsella
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rigel Pharmaceuticals Inc
Original Assignee
Rigel Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rigel Pharmaceuticals Inc filed Critical Rigel Pharmaceuticals Inc
Application granted granted Critical
Publication of DE60040348D1 publication Critical patent/DE60040348D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G01N33/5023—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects on expression patterns
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6897—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Wood Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE60040348T 1999-11-12 2000-11-13 R verwendung des diphtheria-toxins Expired - Lifetime DE60040348D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16518999P 1999-11-12 1999-11-12
PCT/US2000/031232 WO2001034806A2 (en) 1999-11-12 2000-11-13 Methods and compositions for screening using diphtheria toxin constructs

Publications (1)

Publication Number Publication Date
DE60040348D1 true DE60040348D1 (de) 2008-11-06

Family

ID=22597844

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60040348T Expired - Lifetime DE60040348D1 (de) 1999-11-12 2000-11-13 R verwendung des diphtheria-toxins

Country Status (8)

Country Link
EP (1) EP1261705B1 (de)
JP (1) JP2003513670A (de)
AT (1) ATE409227T1 (de)
AU (1) AU2904401A (de)
CA (1) CA2396626A1 (de)
DE (1) DE60040348D1 (de)
DK (1) DK1261705T3 (de)
WO (1) WO2001034806A2 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7090976B2 (en) 1999-11-10 2006-08-15 Rigel Pharmaceuticals, Inc. Methods and compositions comprising Renilla GFP
US7060433B1 (en) * 1999-11-12 2006-06-13 Rigel Pharmaceuticals, Inc. Methods and compositions for screening using diphtheria toxin constructs
DE60032927T2 (de) * 1999-11-10 2007-11-08 Rigel Pharmaceuticals, Inc., South San Francisco Verfahren and zusammenstellungen, die renilla gfp enthalten
AU2003225727A1 (en) * 2002-03-08 2003-09-22 Rigel Pharmaceuticals, Inc. COMPOUNDS THAT MODULATE PROCESSES ASSOCIATED WITH IgE PRODUCTION AND METHODS AND KITS FOR IDENTIFYING AND USING THE SAME
US20030170724A1 (en) 2002-03-08 2003-09-11 Anderson David C. Methods of identifying target polypeptides
US7189523B2 (en) 2002-07-16 2007-03-13 Rigel Pharmaceuticals, Inc. Methods of identifying compounds that modulate IL-4 receptor-mediated IgE synthesis utilizing a B-cell associated protein
JP2010504507A (ja) * 2006-09-20 2010-02-12 インスティチュート・パスツール・コリア 細胞におけるターゲットタンパク質候補の発現を検出および／または定量する方法、ならびに小分子モデュレーターのターゲットタンパク質を同定する方法
KR101482187B1 (ko) * 2013-01-14 2015-01-14 (주)넥스젠바이오텍 녹색형광단백질―인간상피세포재생인자 융합단백질의 생산을 위한 유전자 컨스트럭트 및 이를 이용한 녹색형광단백질-인간상피세포재생인자 융합단백질의 생산방법
KR101661912B1 (ko) 2016-01-29 2016-10-04 (주)넥스젠바이오텍 녹색형광단백질-인간 상피세포재생인자 융합단백질을 유효성분으로 포함하는 주름 개선 및 항노화 화장료 조성물

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3724495A (en) * 1994-09-13 1996-03-29 Prizm Pharmaceuticals, Inc. Conjugates of heparin-binding epidermal growth factor-like growth factor with targeted agents
US7001733B1 (en) * 1998-05-12 2006-02-21 Rigel Pharmaceuticals, Inc. Methods and compositions for screening for modulations of IgE synthesis, secretion and switch rearrangement

Also Published As

Publication number Publication date
JP2003513670A (ja) 2003-04-15
CA2396626A1 (en) 2001-05-17
WO2001034806A9 (en) 2002-07-04
EP1261705B1 (de) 2008-09-24
AU2904401A (en) 2001-06-06
EP1261705A2 (de) 2002-12-04
WO2001034806A3 (en) 2001-11-29
WO2001034806A2 (en) 2001-05-17
DK1261705T3 (da) 2009-02-02
ATE409227T1 (de) 2008-10-15

Similar Documents

Publication Publication Date Title
NO20061736L (no) Krystallform av epotilon B
ATE466072T1 (de) Bandscheibe
IL151313A0 (en) Lipase containing pharmaceutical compositions
DE60122767D1 (de) Indoly-lsulphonyl-verbindungen zur behandlung von störungen des zns
MXPA02004666A (es) Gelatinas recombinantes.
DE60013098D1 (de) Zusammensetzung zur hautdesinfizierung
DE69939864D1 (de) Ppar-gamma modulatoren
MXPA02006029A (es) Lipopeptidos novedosos como agentes antibacterianos.
ATE271058T1 (de) Mycophenol bisphosponatverbindungen
HK1080467B (zh) 用於治療過度增生疾病的苯並呋喃和苯並噻吩衍生物
BR0113162A (pt) Ariloxialquilaminas nao-imidazóis
ATE412649T1 (de) Substituierte heteroarylbenzofuransäuren
ES2177316T3 (es) Anticuerpos humanos antifacotores ix/ixa.
DE60040348D1 (de) R verwendung des diphtheria-toxins
NO20031860D0 (no) Kahalaolid F
DK1213974T3 (da) Direkte komprimerbart råstof til komprimate
TR200200278T2 (tr) Kalsilitik bileşimler
DK0939769T3 (da) Vertebrat-Smoothened-proteiner
BR0108187A (pt) Moléculas trade e usos relacionados com as mesmas
HK1076735A1 (en) Antigen-specific ige antibody production inhibitors
DE69409961D1 (de) Triarylethylenderivate zur therapeutischen verwendung
RS20060023A (en) Use of soluble cd164 in inflammatory and/or autoimmune disorders
AU6871501A (en) Cgi-69 compositions and methods of use
NO20021429L (no) 1,4-dioksacykloalkan-2-oner og 1,4-dioksacykloalken-2-oner
ATE265418T1 (de) Neue substituierte 3-phenoxy- und 3- phenylalkyloxy-2-phenyl-propylamine

Legal Events

Date Code Title Description
8364 No opposition during term of opposition